BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM

Similar documents
BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM. 1 April 13

Report generated from MPH Formulary provided by FormularyComplete ( Accessed Formulary Status. TA Number.

GASTRO-INTESTINAL SYSTEM 1.1 Dyspepsia and gastro-oesophageal reflux disease

BNF CHAPTER 1: GASTROINTESTINAL

Chapter 1 Gastro-Intestinal System

Chapter 1 Gastro-Intestinal System

1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->aluminium-magnesium complexes->hydrotalcite->with simeticone

Report generated from Joint Formulary provided by FormularyComplete ( Accessed TA Number

1. Gastro-intestinal system

Primary Care Constipation Guidelines. Version 1 November 2016

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic

Gastrointestinal system

Constipation an Old Friend. Presented by Dr. Keith Harris

Guidelines for the Management of Constipation: Adult Patients

Cambridgeshire Community Pharmacy Minor Ailments Service. February 2009

What Is Constipation?

GASTROINTESTINAL SYSTEM MANAGEMENT OF DYSPEPSIA

BNF/BNFC Chapter 1 Gastro-intestinal System

MCA Training Made Easy

Understanding your take home medications from the surgical ward. Information for Patients

Protocol to support reducing the use of and the effective use of laxatives. HaRD CCG employed Pharmacists and Medicines Optimisation Technicians.

3.4 gram/7 gram powder -- $5.63

Chapter 5 Gastroenterology. Dose. Route. Units. Given. Dose. Route. Units. Given

ASSESSMENT OF THE PAEDIATRIC NEEDS GASTRO-ENTEROLOGY DISCLAIMER

July Formulary Policy

Care at the Chemist. Formulary

Pharmacology. Drugs that Affect the Gastrointestinal System

Treat primary. symptoms. Offer general lifestyle advice. Manage IBS according to the dominant symptom. Follow up. Symptoms do not improve

Care at the Chemist. Formulary

Constipation. Myeloma Infosheet Series. Symptoms and complications. Infoline:

Antidiarrheals Antidiarrheal

Reflux of gastric contents, particularly acid, into the esophagus

Advance Notification of Amendments to the March 2018 Drug Tariff

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

1 Gastro-intestinal system

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.

Laxative Policy THIS POLICY MUST BE READILY ACCESSIBLE AT ALL TIMES AND AT THE POINT WHERE MEDICINES ARE USED.

Gastrointestinal Involvement in Adult Mitochondrial Disease

Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment

Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017

1 Gastro-intestinal system

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl

Constipation. What are the signs and symptoms of constipation? Less than three bowel movements per week. Pain or discomfort when opening your bowels

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES

Elderly Man With Chronic Constipation

Advancing gastroenterology, improving patient care

Constipation. What is constipation? What causes constipation? How common is constipation?

Examples of prices, license restrictions and availability of common over the counter medications.

A patient s guide to the. management of constipation following surgery

Second term/

SELF CARE AND OTC MEDICINES ON PRESCRIPTION

A guide to Anoplasty (anal surgery)

Opioid constipation treatment dulcolax

DULCOLAX Tablets and Suppositories Bisacodyl

Constipation. AL amyloidosis Infosheet Series. Symptoms and complications. Infoline:

The management of constipation in adults

Difference between omeprazole and omeprazole delayed release

Diarrhoea. Myeloma Infosheet Series. Symptoms and complications. Infoline:

ABC of palliative care: Constipation and diarrhoea

MANAGEMENT OF DYSPEPSIA AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

Medications and ostomies. Sarah Drost, BSc Pharm, RPh, ACPR

Technology appraisal guidance Published: 15 December 2010 nice.org.uk/guidance/ta211

Bowel Management, Community Nursing

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 14 September 2011

Gateshead Primary Care Formulary Incorporating Gateshead Medicines Management Committee, Gateshead NHS Foundation Trust and North of Tyne Area

Irritable Bowel Syndrome (IBS)

Doncaster & Bassetlaw Cancer Locality. Palliative Care Core Formulary

Protectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry

Algorithms & Information Sheets

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August

Bisacodyl Laxative (Pharmacy Health)

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Gastro-intestinal System

Inhaled Therapy - for further information, see LTHT Nebuliser Guidelines for Adults or Children

Gastrointestinal disturbances

AL amyloidosis Infosheet

Medical therapies and IBD

Homely Remedies Guidance

Office of Medicaid Policy and Planning Over-the-Counter Drug Formulary ANALGESICS ANTACIDS ANTI-FLATULENTS

Guideline scope Diverticular disease: diagnosis and management

Prescribing Formulary. 6 th Edition October 2009

Dumfries & Galloway Minor Ailments Service Formulary 2014

Constipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk

Gastrointestinal disturbances


EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE

Constipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation?

Management of Reflux and GORD

Self-care aware When should you prescribe?

WORKING PARTY ON HERBAL MEDICINAL PRODUCTS FINAL PROPOSAL FOR A CORE DATA FOR ISPAGHULA HUSK

Gateshead Formulary. Adapted with thanks from Formulary document prepared by Pharmicus

Aminosalicylates in Inflammatory Bowel Disease in Adults (Review date: July 2020) Page 1

Dulcolax 5 mg, film-coated tablets

Managing constipation in adults with co-morbidities

MAS Formulary Products

Prescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry

Transcription:

BNF CHAPTER 1: GASTRO-INTESTINAL SYSTEM 1

ANTACIDS Maalox and Peptac are effective antacids that can be bought Over the Counter for self-limiting symptoms. Choice Product Cost Effective Options &Comments Co-Magaldrox 175mg//200mg/5ml Suspension Prescribe the brand Maalox Alginate Raft forming oral suspension or liquid Prescribe the brand Peptac (Compound Alginates) ANTISPASMODICS Choice Drug Cost Effective Options & Comments Mebeverine 135mg tablets Hyoscine Butylbromide tablets Colofac IBS is available OTC for self-limiting symptoms Buscopan Cramps is available OTC for self-limiting symptoms Note: Antispasmodics offer little benefit in irritable bowel syndrome and diverticular disease, where pain is a predominant symptom. 2

H 2 - RECEPTOR ANTAGONISTS Choice Drug Comments and Cost Effective Options Ranitidine Rantidine 75mg/5ml oral solution is a licensed cost effective option for patients with swallowing difficulties or a fitted PEF/NG tube. Dose should be optimised for liquid doses where applicable. Ranitidine 5mg/5ml oral suspension(unlicensed) is more cost effective than the 5mg/5ml solution Avoid prescribing Zantac Relief, Gavilast 75mg and Ranitidine 75mg which are available OTC for self-limiting symptoms. PROTON PUMP INHIBITORS Choice Drug Cost Effective Options & Comments Omeprazole caps or Lansoprazole caps Dispersible versions should be prescribed for patients with swallowing difficulties or those with a PEG or NG tube. Omeprazole 10mg/5ml and 20mg/5ml are unlicensed formulations Omeprazole 10mg (cap/tab) is available OTC for self-limiting conditions Pantoprazole tablets Note: For Barrett s esophagus and other disease complicated by stricture, recurrent ulceration or hemorrhage, full dose should be maintained. 3

ANTI-DIARRHOEAL DRUGS Choice Drug Cost Effective Options & Comments Loperamide 2mg capsules Codeine Phosphate 30mg or 60mg tablets Prescribe Loperamide 1mg/5ml oral solution S/F for patients with swallowing difficulties or those fitted with a PEG or NG tube Loperamide is available OTC as generic and Imodium formulations for self-limiting conditions Avoid prescribing Imodium melts as not a cost effective option. Codeine 25mg/5ml oral solution can be prescribed for patients with swallowing difficulties or those fitted with a PEG or NG tube. Drug therapy should be avoided in acute diarrhoea, particularly in the young and elderly. Consider Clostridium difficile Infection (CDI). Has the patient been in hospital recently? CDI affects the elderly, the debilitated and patients who have had antibiotic treatment. Antimotility drugs should not be prescribed in acute CDI, and a stool specimen should be considered. Ref: " CDI: How to deal with the problem" (HPA -DH - Jan-09) Fluid replacement is of the essence. AMINOGLYCOSATES Choice Drug Cost Effective Options and Comments There is no evidence to show that any one oral preparation of Mesalazine is more effective than another; however, the delivery characteristics of oral Mesalazine preparations may vary. Mesalazine MR 400mg Octasa MR 400mg tablets Patients with swallowing difficulties or fitted with a PEG or NG tube should be prescribed Asacol suppositories Other dose dependent options are Salofalk and Pentasa granules. 4

BULK-FORMING LAXATIVES Choice Drug Cost Effective options Ispaghula Husk Methylcellulose tablets One sachet is equivalent to 2 level 5ml spoonsful Isphaghula is available OTC as Fybogel and other generic forms for self-limiting symptoms Celevac is available OTC for self limiting symptoms OSMOTIC LAXATIVES Choice Product Cost Effective Options Macrogol oral compound powder Lactulose Solution Prescribe the brand Laxido (Paediatric & Adult ) Macrogol other branded generic brands are available OTC for self-limiting symptoms. Avoid prescribing the sachets Not recommended for use in inflammatory bowel disease Lactulose and other generic brands are available OTC for self-limiting symptoms 5

STIMULANT LAXATIVES Choice Product Cost Effective Options Bisacodyl Prescribe Generic.Available OTC for self limiting symptoms Senna 7.5mg.Available OTC for self-limiting symptoms Avoid prescribing Senna 15mg Prescribe Senna 7.5mg/5ml for patients with swallowing difficulties or fitted with a PEG or NG tube should be prescribed. RECTAL OPTIONS Choice Product Cost Effective Options & Comments Glycerol 4g suppositories Bisacodyl 5mg/10mg suppositories OR Docusate 120mg enema Third Sodium Citrate Relaxit Micro-Enema 6

Choice Product Cost Effective Options & Comments Lubiprostone 24mg NICE TA 318 For consideration, if at least two laxatives from different classes have been tried at the highest tolerated recommended doses for at least 6 months, and failed to relieve symptoms, where invasive treatment (such as suppositories, enemas, rectal irrigation and/or manual disimpaction) is being considered. Should only be prescribed in line with NICE guidelines Other drugs Linaclotide Naloxegol NICE TA345 (2105) HOSPITAL ONLY Co-Danthramer If treatment is not effective after 2 weeks, the person should be re-examined and the benefit of continuing treatment reconsidered. for the symptomatic treatment of moderate-to-severe irritable bowel syndrome with constipation (IBS-C) in adults Only for opioid induced constipation where response to other laxatives is inadequate. An inadequate response is defined as opioid-induced constipation symptoms of at least moderate severity in at least 1 of the 4 stool symptom domains (that is, incomplete bowel movement, hard stools, straining or false alarms) while taking at least 1 laxative class for at least 4 days during the prior 2 weeks. Should only be prescribed in line with NICE guidelines Licensed for constipation in terminally ill patients. Available as suspension 7

PREPARATIONS FOR ACUTE HAEMORRHOIDS Choice Product Cost Effective Options & Comments Zinc oxide 10.75% + bismuth oxide 2.14% + balsam peru 1.8% Hydrocortisone 0.5% + zinc oxide 12.35% + Peru balsam 1.85% + benzyl benzoate 1.2% + Bismuth oxide 0.875% Hydrocortisone / Cinchocaine 5mg /5mg Prescribe as Anusol cream. Available over the counter. Prescribe as Anusol HC cream. Available over the counter as Anusol Plus Ointment Uniroid HC Ointment Uniroid HC Suppositories BNF 1.7.4 MANAGEMENT OF CHRONIC ANAL FISSURES (Present for > 6 weeks) Choice Product Cost Effective Options Glyceryl trinitrate 0.4% Rectal ointment Diltiazem 2% ointment (unlicensed) Diltiazem Ointment is the most cost effective option as it currently costs less than 50% compared to the cream Rectogesic is the only licensed product currently available in the UK Diltiazem ointment acts as a smooth muscle relaxant. The Association of Coloproctology of Great Britain and Ireland states a preference for topical diltiazem over GTN as it has similar efficacy to Glyceryl Trinitrate but a lower incidence of side effects. It is not recommended for long term use. Typical duration of use 6-8 weeks. 8

NAUSEA AND VOMITTING Choice Product Cost Effective Options Prochloperazine tablets Caution: can cause extrapyramidal side effects. Increased risk of drug-induced parkinsonism in the elderly particularly after prolonged use Domperidone or Metoclopramide Domperidone caution: risk of cardiac side effects. Use restricted to nausea and vomiting only. The maximum treatment duration should not usually exceed one week. - MHRA 2014 Metoclopramide caution: Risk of neurological adverse effects. Treatment with metoclopramide should not be prescribed for longer than 5 days. MHRA 2013 TRANS ANAL IRRIGATION APPLIANCES: NICE recently approved the use of Trans anal irrigation kits for bowel dysfunction and should be offered as part of a supportive bowel care programme. Trans Anal Irrigation Products currently available on prescription. Table below is based on daily irrigation PS: IryPump S cones are re-usable and last up to 3 months with every day use 9

Product Name Cost of System Features How often is this replaced? Cost of Catheters based on daily usage How often is this replaced? Other consumables e.g. bags tubes (Misc) Cost Y1 Cost Y2 Cost Y3 Total Estimated Costs IryPump S 498.76 Electric 3-4years 61.19 Every 3 Water bags tubes 744 245 245 1,234.00 Set months Peristeen 76.90 Manual 3 months 270.00 monthly Water bags tubes 3547 3547 3547 10,641.00 Qufora 99.00 Manual +15 catheters Qufora 101.66 Manual + 15 cones Navina 300.92 Electric+ monthly 15 extra req. 115 monthly 15 extra req. cones 59 18-24 260 for 30 Smart 2 cones months cones Aquaflush 35.00 Manual monthly 118 for 30 cones monthly Water bags tubes 2568 2568 2568 7,704.00 Monthly Water bags tubes 1928 1928 1928 5,784.00 Monthly Water bags tubes 3420 3120 3420 10,260.00 monthly Water bags tubes 1836 1836 1836 5,508.00 Formulary Chapter 1 Gastro-intestinal system Date ratified by D&T Committee April 2013 Next Review Date April 2015 1 st Amendment NICE TAG recommendations Reference to self-limiting conditions and OTC options Date ratified by D&T Committee October 2018 Next Review Date October2020 10